The Scientific Executive Committee is tasked with developing, assessing, and implementing a strategic research roadmap to guide LCRF’s research investment and will identify areas of unmet need. In addition, members advise LCRF on collaboration opportunities with multiple stakeholders in lung cancer, including but not limited to pharmaceutical and business partners whose missions align with that of LCRF.
Scientific Executive Committee Members
David P. Carbone, MD, PhD
Professor, Medical Oncology, Molecular, Cellular, and Developmental Biology Graduate Program
The Ohio State University Comprehensive Cancer Center
Ibiayi Dagogo-Jack, MD
Assistant Professor of Medicine
Harvard Medical School
Thoracic Oncologist
Massachusetts General Hospital
Bruce Dunbar
LCRF Board of Directors
Lung cancer survivor
Partner, Coppertop Media
Marc Ladanyi, MD
Chief, Molecular Diagnostics Service
William J. Ruane Chair in Molecular Oncology
Memorial Sloan Kettering Cancer Center
Kathryn O’Donnell, PhD
Associate Professor, Molecular Biology
UT Southwestern
Katerina Politi, PhD
Associate Professor of Pathology and Internal Medicine
Yale School of Medicine
Chair, LCRF Scientific Advisory Board
Brendon M. Stiles, MD
Professor, Department of Cardiothoracic & Vascular Surgery
Chief, Division of Thoracic Surgery & Surgical Oncology
Montefiore-Einstein Cancer Center
Vice Chair, LCRF Board of Directors
Vice Chair, LCRF Scientific Advisory Board
Robert A. Winn, MD
Director & Lipman Chair in Oncology
VCU Massey Cancer Center
Senior Associate Dean for Cancer Innovation
Professor of Pulmonary Disease and Critical Care Medicine
VCU School Of Medicine